{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:51:24Z","timestamp":1791273084634,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.berh.2023.101862","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T21:59:04Z","timestamp":1692395944000},"page":"101862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Peripheral spondyloarthritis: What have we learned?"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1526-0978","authenticated-orcid":false,"given":"Mar\u00eda \u00c1ngeles","family":"Puche-Larrubia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2309-5837","authenticated-orcid":false,"given":"Clementina","family":"L\u00f3pez-Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4479-7678","authenticated-orcid":false,"given":"Nelly","family":"Ziad\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.berh.2023.101862_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2023.101862_bib3","article-title":"Imaging in the diagnosis and management of peripheral psoriatic arthritis","volume":"34","author":"Ramiro","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2023.101862_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001728","article-title":"Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study","volume":"7","author":"L\u00f3pez-Medina","year":"2021","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001136","article-title":"Peripheral spondyloarthritis: a neglected entity-state of the art","volume":"6","author":"Carron","year":"2020","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.berh.2023.101862_bib6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.berh.2019.02.010","article-title":"Peripheral spondyloarthritis: concept, diagnosis and treatment","volume":"32","author":"Molto","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.berh.2023.101862_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152012","article-title":"What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study","volume":"55","author":"Ziade","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101862_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/ard.2004.033654","article-title":"Seronegative spondyloarthropathies: to lump or split?","volume":"64","author":"Nash","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101862_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3899\/jrheum.190867","article-title":"To lump or split when assessing psoriatic arthritis - not mutually exclusive?","volume":"47","author":"Tillett","year":"2020","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2023.101862_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1759720X20971889","article-title":"Axial spondyloarthritis and axial psoriatic arthritis: similar or different disease spectrum?","volume":"12","author":"Benavent","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001450","article-title":"Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study","volume":"7","author":"L\u00f3pez-Medina","year":"2021","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.berh.2023.101862_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002592","article-title":"Peripheral spondyloarthritis and psoriatic arthritis sine psoriase: are we dealing with semantics or clinically meaningful differences?","volume":"8","author":"Ziade","year":"2022","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.berh.2023.101862_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3899\/jrheum.220312","article-title":"Management of enthesitis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations","volume":"50","author":"Eder","year":"2023","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2023.101862_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101594","article-title":"Imaging in the diagnosis and management of peripheral psoriatic arthritis","volume":"34","author":"Aydin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/rheumatology\/keac235","article-title":"The impact of psoriasis on the clinical characteristics, disease burden and treatment patterns of peripheral spondyloarthritis","volume":"62","author":"Izci Duran","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101862_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.847312","article-title":"Harnessing big data, smart and digital technologies and artificial intelligence for preventing, early intercepting, managing, and treating psoriatic arthritis: insights from a systematic review of the literature","volume":"13","author":"Bragazzi","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.berh.2023.101862_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001845","article-title":"Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis","volume":"7","author":"Pournara","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2023.101862_bib18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3899\/jrheum.181331","article-title":"Peripheral manifestations in spondyloarthritis and their effect: an ancillary analysis of the ASAS-COMOSPA study","volume":"47","author":"L\u00f3pez-Medina","year":"2020","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2023.101862_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2014-eular.4951","article-title":"First results from \u201cbe-giant\u201d: baseline characteristics of an early spondyloarthritis cohort","volume":"73","author":"Varkas","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101862_bib20","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.semarthrit.2015.09.001","article-title":"Similarities and differences between patients fulfilling axial and peripheral ASAS criteria for spondyloarthritis: results from the Esperanza Cohort","volume":"45","author":"del R\u00edo-Mart\u00ednez","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.berh.2023.101862_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2018-000802","article-title":"Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis","volume":"5","author":"De Winter","year":"2019","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.berh.2023.101862_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/annrheumdis-2013-204436","article-title":"Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort","volume":"74","author":"Costantino","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2023.101862_bib23","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2023.101862_bib24","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","article-title":"Genetics of spondyloarthritis \u2014 beyond the MHC","volume":"8","author":"Reveille","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2023.101862_bib25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2018MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.berh.2023.101862_bib26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.berh.2023.101862_bib27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1084\/jem.194.4.519","article-title":"Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense","volume":"194","author":"Ye","year":"2001","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.berh.2023.101862_bib28","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","article-title":"IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis","volume":"74","author":"Adamopoulos","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101862_bib29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4049\/jimmunol.1003986","article-title":"IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass","volume":"187","author":"Adamopoulos","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.berh.2023.101862_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/BOR.0000000000000946","article-title":"Human leucocyte antigen-B27 testing in clinical practice: a global perspective","volume":"35","author":"Ziade","year":"2023","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"10.1016\/j.berh.2023.101862_bib31","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","article-title":"Axial spondyloarthritis","volume":"80","author":"Navarro-Comp\u00e1n","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2023.101862_bib32","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.berh.2023.101862_bib33","first-page":"957","volume":"376","author":"Ritchlin","year":"2017","journal-title":"Psoriatic Arthritis. N Engl J Med."},{"issue":"3","key":"10.1016\/j.berh.2023.101862_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.berh.2006.03.007","article-title":"Enthesitis","volume":"20","author":"D'Agostino","year":"2006","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"4","key":"10.1016\/j.berh.2023.101862_bib35","first-page":"561","article-title":"Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort","volume":"37","author":"Nadon","year":"2019","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2017.12.008","article-title":"Enthesitis: a hallmark of psoriatic arthritis","volume":"48","author":"Kaeley","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2023.101862_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.semarthrit.2018.02.002","article-title":"Dactylitis: a hallmark of psoriatic arthritis","volume":"48","author":"Kaeley","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2023.101862_bib38","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/rheumatology\/kex057","article-title":"Ocular involvement in patients with spondyloarthritis","volume":"56","author":"Bacchiega","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2023.101862_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221119246","article-title":"Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study","volume":"14","author":"Llop","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001777","article-title":"Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs","volume":"8","author":"Schwartzman","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2023.101862_bib41","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/rheumatology\/kez172","article-title":"Performance of magnetic resonance imaging in the diagnosis of axial spondyloarthritis: a systematic literature review","volume":"58","author":"Jones","year":"2019","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.berh.2023.101862_bib42","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/annrheumdis-2016-210775","article-title":"Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study","volume":"76","author":"Carron","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2023.101862_bib43","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2014-206971","article-title":"EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice","volume":"74","author":"Mandl","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2023.101862_bib44","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1093\/rheumatology\/keac567","article-title":"Performance of an MRI scoring system for inflammation of joints and entheses in peripheral SpA: post-hoc analysis of the CRESPA trial","volume":"62","author":"Krabbe","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.berh.2023.101862_bib45","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/ard.2010.134965","article-title":"Diagnostic accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis","volume":"70","author":"de Miguel","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2023.101862_bib46","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/annrheumdis-2018-213609","article-title":"Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative","volume":"77","author":"Balint","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.berh.2023.101862_bib47","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1093\/rheumatology\/keac162","article-title":"Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based study","volume":"61","author":"Di Matteo","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.berh.2023.101862_bib48","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/rheumatology\/keu399","article-title":"Can we use enthesis ultrasound as an outcome measure of disease activity in spondyloarthritis? A study at the Achilles level","volume":"54","author":"Falcao","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib49","first-page":"31","article-title":"Assessment of enthesis in patients with psoriatic arthritis and fibromyalgia using clinical examination and ultrasound","volume":"38","author":"Fiorenza","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2023.101862_bib50","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13075-018-1724-7","article-title":"Influence of HLA-B27 on the ankylosing spondylitis phenotype: results from the REGISPONSER database","volume":"20","author":"Ar\u00e9valo","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2023.101862_bib51","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1136\/ard.2011.152975","article-title":"HLA-B27 positive patients differ from HLA-B27 negative patients in clinical presentation and imaging: results from the DESIR cohort of patients with recent onset axial spondyloarthritis","volume":"70","author":"Chung","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2023.101862_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002696","article-title":"Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study","volume":"8","author":"Arevalo Salaet","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.berh.2023.101862_bib53","first-page":"85","article-title":"[Criteria of the classification of spondylarthropathies]","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"10.1016\/j.berh.2023.101862_bib54","first-page":"293","article-title":"Evaluation of the Amor and ESSG classification criteria for spondylarthropathies in a Turkish population","volume":"64","author":"Erturk","year":"1997","journal-title":"Rev du Rhum (English Ed)"},{"issue":"5","key":"10.1016\/j.berh.2023.101862_bib55","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/annrheumdis-2016-210747","article-title":"Performance of the ASAS classification criteria for axial and peripheral spondyloarthritis: a systematic literature review and meta-analysis","volume":"76","author":"Sepriano","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2023.101862_bib56","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"Suppl4","key":"10.1016\/j.berh.2023.101862_bib57","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1093\/rheumatology\/keaa250","article-title":"Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis","volume":"59","author":"Poddubnyy","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.berh.2023.101862_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.rdc.2016.02.002","article-title":"Patient-reported outcomes in rheumatic diseases","volume":"42","author":"Weisman","year":"2016","journal-title":"Rheum Dis Clin N Am"},{"issue":"7","key":"10.1016\/j.berh.2023.101862_bib59","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/annrheumdis-2014-207235","article-title":"A\u00a0psychometric analysis of outcome measures in peripheral spondyloarthritis","volume":"75","author":"Turina","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.berh.2023.101862_bib60","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.39008","article-title":"Randomized controlled trial of adalimumab in patients with nonpsoriatic peripheral spondyloarthritis","volume":"67","author":"Mease","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2023.101862_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3899\/jrheum.211043","article-title":"How should we measure peripheral spondyloarthritis?","volume":"49","author":"Coates","year":"2022","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.berh.2023.101862_bib62","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1136\/annrheumdis-2012-202245","article-title":"Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis","volume":"72","author":"Paramarta","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2023.101862_bib63","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3899\/jrheum.210075","article-title":"Performance of 3 composite measures for disease activity in peripheral spondyloarthritis","volume":"49","author":"Beckers","year":"2022","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2023.101862_bib64","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/ard.2009.122259","article-title":"Application of the DAREA\/DAPSA score for assessment of disease activity in psoriatic arthritis","volume":"69","author":"Schoels","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2023.101862_bib65","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/annrheumdis-2016-209511","article-title":"Disease activity states of the DAPSA, a psoriatic arthritis specific instrument, are valid against functional status and structural progression","volume":"76","author":"Aletaha","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2023.101862_bib66","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/annrheumdis-2012-201341","article-title":"The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)","volume":"72","author":"Helliwell","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2023.101862_bib67","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/annrheumdis-2016-211010","article-title":"Modification of the psoriatic arthritis disease activity score (PASDAS)","volume":"77","author":"Helliwell","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2017-212178","article-title":"An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS","volume":"77","author":"Molto","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2023.101862_bib69","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2019-001002","article-title":"Measurement properties of the minimal disease activity criteria for psoriatic arthritis","volume":"5","author":"Coates","year":"2019","journal-title":"RMD Open"},{"issue":"2","key":"10.1016\/j.berh.2023.101862_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/acr.24442","article-title":"Performance and predictors of minimal disease activity response in patients with peripheral spondyloarthritis treated with adalimumab","volume":"74","author":"Coates","year":"2022","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.berh.2023.101862_bib71","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1136\/ard.2009.121533","article-title":"A\u00a0randomised, multicentre, double-blind, placebo controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial","volume":"69","author":"Dougados","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2023.101862_bib72","series-title":"Managing spondyloarthritis in adults - NICE Pathways","year":"2021"},{"key":"10.1016\/j.berh.2023.101862_bib73","first-page":"32","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Helena Marzo-Ortega"},{"key":"10.1016\/j.berh.2023.101862_bib74","first-page":"52","article-title":"GRAPPA treatment recommendations: 2021 update","volume":"49","author":"Coates","year":"2022","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2023.101862_bib75","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694223000487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:24:43Z","timestamp":1761499483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694223000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":75,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1521694223000487"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2023.101862","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral spondyloarthritis: What have we learned?","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2023.101862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101862"}}